Drugs / Adenosine Monophosphate
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03738943 | Feb 2019 → Jun 2021 | — | Colorado State University | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT02574975 | Apr 2015 → May 2016 | asthma | Zhujiang Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adenosine Monophosphate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03738943 ↗ |
| Route | Inhaled | “Adenosine monophosphate ,inhaled cumulative dosage 40mg” NCT02574975 ↗ |